SPAIN | ACTIS
06/11/2019
Límite 15 Oct 2022
Oferta Tecnológica
Ref.
TOLU20211001001
Novel prognostic and predictive biomarker for colorectal cancer
A research team from an university in Luxembourg has identified a new biomarker to early diagnose patients with colorectal cancer. This enhances patients' chances of survival and disease cure. The Luxembourg university is willing to engage with a diagnostic company to further develop and commercialize the biomarker, through license agreement or technical cooperation agreement.
Socios

logotipo CEOE Aragónlogotipo ITAlogotipo Cámara Toledologotipo FEDAlogotipo UCLM
logotipo FUNDECYT-PCTEX logotipo ADERlogotipo FERlogotipo AINlogotipo UNAV

27/02/2024

Requerimientos: IE 6.0+, FF 1.5+ 1024x768+ | Aviso Legal | Confidencialidad

06/11/2019